TP53 and cancer: The high sensitivity of cancer cells to the counteraction of Warburg effect has been considered a valuable target in anticancer therapy; in particular, activation of p53, a major regulator of glucose metabolism, can conduct to a robust inhibition of energy production in cancer cells and subsequently to their efficient elimination.